Research Solutions Inc (RSSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,866 | -1,266 | -590 | -143 | 192 |
| Depreciation Amortization | 220 | 155 | 98 | 48 | 618 |
| Accounts receivable | -179 | -566 | -484 | 62 | 1,133 |
| Other Working Capital | 616 | -26 | -319 | 61 | -1,048 |
| Other Operating Activity | 1,686 | 1,535 | 955 | 108 | -990 |
| Operating Cash Flow | $476 | $-167 | $-339 | $136 | $-96 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17 | -4 | -4 | -1 | 473 |
| Purchase Sale Intangibles | -54 | -41 | -16 | -4 | -22 |
| Other Investing Activity | -84 | -71 | -35 | -4 | -22 |
| Investing Cash Flow | $-101 | $-75 | $-39 | $-4 | $451 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -1,000 |
| Debt Repayment | N/A | N/A | N/A | N/A | -739 |
| Common Stock Issued | 838 | 838 | 838 | N/A | N/A |
| Other Financing Activity | -577 | -410 | -209 | -8 | -51 |
| Financing Cash Flow | $261 | $428 | $629 | $-8 | $-1,790 |
| Exchange Rate Effect | -58 | -36 | -42 | -28 | -16 |
| Beginning Cash Position | 1,307 | 1,307 | 1,307 | 1,307 | 3,151 |
| End Cash Position | 1,885 | 1,457 | 1,515 | 1,403 | 1,700 |
| Net Cash Flow | $578 | $150 | $209 | $96 | $-1,451 |
| Free Cash Flow | |||||
| Operating Cash Flow | 476 | -167 | -339 | 136 | -96 |
| Capital Expenditure | -17 | -4 | -4 | -1 | -101 |
| Free Cash Flow | 459 | -171 | -343 | 135 | -197 |